222 related articles for article (PubMed ID: 32162442)
21. NAA10 mutation causing a novel intellectual disability syndrome with Long QT due to N-terminal acetyltransferase impairment.
Casey JP; Støve SI; McGorrian C; Galvin J; Blenski M; Dunne A; Ennis S; Brett F; King MD; Arnesen T; Lynch SA
Sci Rep; 2015 Nov; 5():16022. PubMed ID: 26522270
[TBL] [Abstract][Full Text] [Related]
22. Letter to the Editor regarding "The role of N-acetyltransferases in cancers": N-alpha acetyltransferase 10 (NAA10) and N-acetyltransferase 10 (NAT10) are distinct genes.
Koufaris C; Nicolaidou V; Kirmizis A
Gene; 2024 Mar; 898():148087. PubMed ID: 38128791
[No Abstract] [Full Text] [Related]
23. RNA interference screen identifies NAA10 as a regulator of PXR transcription.
Oladimeji PO; Wright WC; Wu J; Chen T
Biochem Pharmacol; 2019 Feb; 160():92-109. PubMed ID: 30566892
[TBL] [Abstract][Full Text] [Related]
24. NAA10 overexpression dictates distinct epigenetic, genetic, and clinicopathological characteristics in adult gliomas.
Le MK; Vuong HG; Nguyen TTT; Kondo T
J Neuropathol Exp Neurol; 2023 Jun; 82(7):650-658. PubMed ID: 37253389
[TBL] [Abstract][Full Text] [Related]
25. ARD1/NAA10 acetylation in prostate cancer.
Kuhns KJ; Zhang G; Wang Z; Liu W
Exp Mol Med; 2018 Jul; 50(7):1-8. PubMed ID: 30054487
[TBL] [Abstract][Full Text] [Related]
26. KAT6A, a chromatin modifier from the 8p11-p12 amplicon is a candidate oncogene in luminal breast cancer.
Turner-Ivey B; Guest ST; Irish JC; Kappler CS; Garrett-Mayer E; Wilson RC; Ethier SP
Neoplasia; 2014 Aug; 16(8):644-55. PubMed ID: 25220592
[TBL] [Abstract][Full Text] [Related]
27. Profiling Cellular Substrates of Lysine Acetyltransferases GCN5 and p300 with Orthogonal Labeling and Click Chemistry.
Han Z; Chou CW; Yang X; Bartlett MG; Zheng YG
ACS Chem Biol; 2017 Jun; 12(6):1547-1555. PubMed ID: 28426192
[TBL] [Abstract][Full Text] [Related]
28. The many lives of KATs - detectors, integrators and modulators of the cellular environment.
Sheikh BN; Akhtar A
Nat Rev Genet; 2019 Jan; 20(1):7-23. PubMed ID: 30390049
[TBL] [Abstract][Full Text] [Related]
29. Inhibitors of histone acetyltransferases KAT6A/B induce senescence and arrest tumour growth.
Baell JB; Leaver DJ; Hermans SJ; Kelly GL; Brennan MS; Downer NL; Nguyen N; Wichmann J; McRae HM; Yang Y; Cleary B; Lagiakos HR; Mieruszynski S; Pacini G; Vanyai HK; Bergamasco MI; May RE; Davey BK; Morgan KJ; Sealey AJ; Wang B; Zamudio N; Wilcox S; Garnham AL; Sheikh BN; Aubrey BJ; Doggett K; Chung MC; de Silva M; Bentley J; Pilling P; Hattarki M; Dolezal O; Dennis ML; Falk H; Ren B; Charman SA; White KL; Rautela J; Newbold A; Hawkins ED; Johnstone RW; Huntington ND; Peat TS; Heath JK; Strasser A; Parker MW; Smyth GK; Street IP; Monahan BJ; Voss AK; Thomas T
Nature; 2018 Aug; 560(7717):253-257. PubMed ID: 30069049
[TBL] [Abstract][Full Text] [Related]
30. Haploinsufficient tumor suppressor Tip60 negatively regulates oncogenic Aurora B kinase.
Bose A; Sudevan S; Rao VJ; Shima H; Trivedi AK; Igarashi K; Kundu TK
J Biosci; 2019 Dec; 44(6):. PubMed ID: 31894128
[TBL] [Abstract][Full Text] [Related]
31. Lysine Acetyltransferases (KATs) in Disguise: Diseases Implications.
Srivastava S; Kumar S; Bhatt R; Ramachandran R; Trivedi AK; Kundu TK
J Biochem; 2023 May; 173(6):417-433. PubMed ID: 36913740
[TBL] [Abstract][Full Text] [Related]
32. Molecular characterization of the histone acetyltransferase CREBBP/EP300 genes in myeloid neoplasia.
Kongkiatkamon S; Pagliuca S; Adema V; Nagata Y; Kerr CM; Walter W; Awada H; Hutter S; Gurnari C; Rogers HJ; Meggendorfer M; Saunthararajah Y; Haferlach T; Visconte V; Maciejewski JP
Leukemia; 2022 Apr; 36(4):1185-1188. PubMed ID: 34845315
[No Abstract] [Full Text] [Related]
33. Roles for lysine acetyltransferases during mammalian hibernation.
Rouble AN; Hawkins LJ; Storey KB
J Therm Biol; 2018 May; 74():71-76. PubMed ID: 29801653
[TBL] [Abstract][Full Text] [Related]
34. Rubinstein-Taybi Syndrome and Epigenetic Alterations.
Korzus E
Adv Exp Med Biol; 2017; 978():39-62. PubMed ID: 28523540
[TBL] [Abstract][Full Text] [Related]
35. Deciphering the structure, function, and mechanism of lysine acetyltransferase cGNAT2 in cyanobacteria.
Jia K; Yang M; Liu X; Zhang Q; Cao G; Ge F; Zhao J
Plant Physiol; 2024 Jan; 194(2):634-661. PubMed ID: 37770070
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of STAT5a by Naa10p contributes to decreased breast cancer metastasis.
Zeng Y; Min L; Han Y; Meng L; Liu C; Xie Y; Dong B; Wang L; Jiang B; Xu H; Zhuang Q; Zhao C; Qu L; Shou C
Carcinogenesis; 2014 Oct; 35(10):2244-53. PubMed ID: 24925029
[TBL] [Abstract][Full Text] [Related]
37. NAA10 promotes proliferation of renal cell carcinoma by upregulating UPK1B.
Zhang ZY; Zhang JL; Zhao LX; Yang Y; Guo R; Zhou N; Liu YR; Zheng GP
Eur Rev Med Pharmacol Sci; 2020 Nov; 24(22):11553-11560. PubMed ID: 33275221
[TBL] [Abstract][Full Text] [Related]
38. The N-end rule pathway enzyme Naa10 supports epiblast specification in mouse embryonic stem cells by modulating FGF/MAPK.
Takekoshi D; Tokuzawa Y; Sakanaka M; Kato H
In Vitro Cell Dev Biol Anim; 2019 May; 55(5):355-367. PubMed ID: 30993557
[TBL] [Abstract][Full Text] [Related]
39. Genotranscriptomic meta-analysis of the CHD family chromatin remodelers in human cancers - initial evidence of an oncogenic role for CHD7.
Chu X; Guo X; Jiang Y; Yu H; Liu L; Shan W; Yang ZQ
Mol Oncol; 2017 Oct; 11(10):1348-1360. PubMed ID: 28649742
[TBL] [Abstract][Full Text] [Related]
40. Genetic alterations of histone lysine methyltransferases and their significance in breast cancer.
Liu L; Kimball S; Liu H; Holowatyj A; Yang ZQ
Oncotarget; 2015 Feb; 6(4):2466-82. PubMed ID: 25537518
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
